GlassScriptPhysician profile
Ling Yi Mei
NPI 1194358028
$1,646.38
in general payments reported to CMS, 2019-2025
23 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $350 · 2023: $310 · 2024: $521 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $314.80 | 2022-2025 | Jelmyto |
| Abbvie INC. | $307.78 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $194.36 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $136.34 | 2021-2025 | Erleada, Akeega |
| Tolmar, INC. | $101.06 | 2023-2025 | Jatenzo, Eligard |
| 180 Medical, INC. | $86.32 | 2023-2025 | |
| Boston Scientific Corporation | $60.37 | 2023-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Ferring Pharmaceuticals INC. | $58.85 | 2024 | Adstiladrin |
| Dentsply Ih Ab | $51.25 | 2023 | Cerec, Lofric |
| Endo USA, INC. | $41.57 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $36.34 | 2023-2024 | Axonics, Bulkamid |
| Alnylam Pharmaceuticals INC. | $35.87 | 2023-2024 | Givlaari |
| Tempus Ai, INC | $31.59 | 2025 | Xt Cdx |
| Urovant Sciences INC | $27.91 | 2022 | |
| Sumitomo Pharma America, INC. | $20.96 | 2023 | Orgovyx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $20.90 | 2022 | |
| Blue Earth Diagnostics | $20.79 | 2021 | |
| Myovant Sciences INC. | $18.39 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $17.73 | 2025 | Lynparza |
| Hollister Incorporated | $17.44 | 2022 | |
| Olympus America INC. | $17.17 | 2024 | Itind System |
| Tolmar Pharmaceuticals, INC. | $15.06 | 2022 | |
| Antares Pharma, INC. | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ling Yi Mei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.